To reimagine and transform venous and lymphatic care through innovative people-centric technologies that improve lives.
Koya Medical was founded through encounters with unmet needs for people with chronic lymphedema. Our CEO and Founder, Andy began researching treatment options when his own family member developed lymphedema after receiving prostate cancer treatment. He quickly observed that traditional at-home therapies, while effective, restricted patient mobility and movement and were difficult to adhere to. An engineer at heart, Andy looked for opportunities to reimagine how therapy can deliver treatment and improve quality of life.
Today, Koya Medical under Andy’s leadership has an expert team of healthcare innovators to develop Dayspring® - the first active compression solution designed to enable movement, mobility and personalized care. Built on a mobile platform using Flexframe® technology, Dayspring provides patients with a portable and easy to use treatment option.
Andy is the founder and President/CEO of Koya Medical, a team dedicated to treating chronic lymphatic and venous disease. Prior to this, Andy developed sight-restoring implants, which have treated more than 6 million patients worldwide. He has deep and wide experience in innovation, technology, and commercialization in healthcare. He received his Ph.D. in biomedical engineering from the School of Medicine at University of North Carolina-Chapel Hill, M.S. in materials science and engineering from University of Arizona, and Bachelor's degree in chemical engineering from University of Madras. He has numerous patents and publications in healthcare innovation. Additionally, Andy is an avid mountaineer and restores vintage motorcycles.
Damian Rippole is a strategic and operationally-focused CFO who brings more than 20 years of financial leadership experience in both private and public medical technology companies. Damian was most recently CFO at Ebb Therapeutics (acquired in a private transaction funded by leading global investment firm KKR), maker of an innovative FDA-cleared device for treating insomnia. Prior to that, Damian was Corporate Controller for Respironics, a global leader in the sleep and respiratory markets that was acquired by Philips for $5 billion in 2008. Following the acquisition, Damian led the global finance integration of Respironics into Philips and served as the group Controller for Philips Home Healthcare Solutions business.
Angela is a trailblazing sales leader who brings an integrated approach, aligning sales functions with all departments to fuel sustainable growth. Angela is passionate about advancing healthcare through evidence-based approaches, and aligns closely with clinicians in order to better serve the needs of the health ecosystem. Angela received her bachelors degree from Iona University, and received her MBA from Iona University’s School of Business. She brings with her over a decade of experience working with leaders in the Vascular and Lymphedema space.
Charles is a seasoned executive with a wide range of experiences across Strategy, R&D, and Commercialization. He has held leadership roles in innovative startups and public Fortune 500 life sciences companies. Charles holds an MBA from the Wharton School, University of Pennsylvania and a Bachelor of Science in Chemistry and Biochemistry from the University of Virginia. He currently resides in San Francisco, California where he regularly hikes with his dog, Wesley.
Maggie is a seasoned healthcare executive with over 25 years leadership experience in the health and medical device industries including innovative start-ups, rapid growth entities, and public companies. Demonstrated success in all areas of medical device reimbursement including development and fruitful implementation of coverage, coding and payment strategies with both government and commercial health insurers.
Jarren started his work in Engineering at NASA Ames Research Center developing prototypes for Interplanetary Drilling and Lunar Plant Growth systems. He has a Bachelor’s degree in Electrical Engineering from the University of Illinois at Chicago and a Master's in Engineering from Stanford University.
Jarren has 10+ years of experience designing hardware and software for novel technologies. His early career began at Oculeve Inc. (acquired by Allergan in 2015) where he developed and scaled the world’s first Class II Intranasal Tear Neurostimulator, TrueTear.
Interested in joining our team?
Want to make a real difference in shaping chronic health? We’d love to hear from you. Koya Medical is always looking for curious and passionate individuals who want to join a fast paced team for a career in transforming venous and lymphatic care.
Jan founded Arboretum Ventures on the premise that innovation is key to delivering value in healthcare, a principle she developed working in the medical device industry for over two decades. Her investments focus on promising medical technologies that enable meaningful healthcare system savings while maintaining great clinical outcomes.
Joe Biller, CFA is a managing partner for American Century Investments®, specializing in private equity investing. Mr. Biller joined American Century Investments in 2023 and has worked in the financial services industry since 2004. Previously he was a managing partner with 3x5 Partners, a managing director with SightLine Partners, and an analyst with Bremer Bank. Mr. Biller received a bachelor’s degree from the University of Wisconsin-Eau Claire. He is a CFA charterholder.
Josh has spent over 25 years in the healthcare industry working across a broad range of responsibilities and companies ranging from early stage product development and innovation to public offerings, mergers and acquisitions for mature companies. He currently serves as a VenturePartner at SightLine partners. Prior to SightLine, he was a Managing Director at Split Rock Partners. He has been a lead investor and board member in companies with an aggregate, realized value of over $2 billion.
Andy is the founder and President/CEO of Koya Medical, a team dedicated to treating chronic lymphatic and venous disease. Prior to this, Andy developed sight-restoring implants, which have treated more than 6 million patients worldwide. He has deep and wide experience in innovation, technology, and commercialization in healthcare. He received his Ph.D. in biomedical engineering from the School of Medicine at University of North Carolina-Chapel Hill, M.S. in materials science and engineering from University of Arizona, and Bachelor's degree in chemical engineering from University of Madras. He has numerous patents and publications in healthcare innovation. Additionally, Andy is an avid mountaineer and restores vintage motorcycles.
Ali has spent over 20 years in the medical technology space leading innovations in home health and ophthalmology. She is Chief Financial Officer at Sight Sciences (NASDAQ: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives in the glaucoma and dry eye space. Previously, she was co-founder and Chief Financial Officer of Inogen, Inc. (NASDAQ: INGN), a leading respiratory technology provider. In addition to serving on the board of directors of Koya Medical, Ali serves on the board of Pear Therapeutics, a prescription digital therapeutics company, and Gelesis Holdings, Inc, (NYSE: GLS), a biotherapeutics company.
.png)
Stanley Rockson, MD, FACP, FACC is the Allan and Tina Neill Professor of Lymphatic Research and Medicine at Stanford University School of Medicine. He serves concurrently as the Stanford’s Chief of Consultative Cardiology and the Director of the Stanford Center for Lymphatic and Venous Disorders. Dr. Rockson is Editor-in-Chief of Lymphatic Research and Biology and sits on the editorial board of Angiology.
Thomas Maldonado, M.D. has been one of New York City’s top vascular surgeons in one of the nation’s premier academic medical centers for over two decades. He is regularly featured as Top Doctor by Castle Connolly and has served as president of numerous national and regional vascular societies.
We are located in Oakland, California where design, development and manufacturing take place.
